“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” states the author of today’s article of the five Buy-rated stocks trading under the $10 level that he highlights. For these five stocks – including a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases – CLICK HERE.
“Sizable Upside Potential”: 5 Buy-Rated Stocks Under $10 For Aggressive Investors
Tags:Aggressive InvestorsBuy-Rated StocksGoldman SachsInvestInvestingShare CountSizeable Upside Potentialstock marketstocksStocks Trading Under $10